Seminoma

Common Name(s)

Seminoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Seminoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Seminoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Seminoma" returned 298 free, full-text research articles on human participants. First 3 results:

Testicular seminoma: Are clinical features and treatment outcomes any different in India?
 

Author(s): M Anjanappa, A Kumar, S Mathews, J Joseph, K M Jagathnathkrishna, F V James

Journal: Indian J Cancer. ;54(1):385-387.

 

This study aims to identify clinical features, treatment outcomes, and prognostic factors for relapse and survival in patients with testicular seminoma.

Last Updated: 31 Dec 1969

Go To URL
Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.
 

Author(s): Yuanlei Chen, Jieyang Lu, Liqun Xia, Dingwei Xue, Xiaoming Yu, Danyang Shen, Liwei Xu, Gonghui Li

Journal: Cancer Sci.. 2018 Feb;109(2):384-394.

 

Seminoma is the most common testicular germ cell tumor worldwide and mainly occurs in 15-35-year-old young men. Early studies have indicated that testicular nuclear receptor 4 (TR4) first cloned from testis is involved in the invasion and metastasis of several human tumors; however, ...

Last Updated: 31 Dec 1969

Go To URL
Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.
 

Author(s): Koji Sakamoto, Satoru Ito, Naozumi Hashimoto, Yoshinori Hasegawa

Journal:

 

Bleomycin-induced lung injury, a major complication of chemotherapy for germ cell tumors, occasionally fails to respond to the standard treatment with corticosteroids and develops into severe respiratory insufficiency. Little is known about salvage treatment for refractory cases.

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Seminoma" returned 34 free, full-text review articles on human participants. First 3 results:

Testicular Seminoma and Its Mimics: From the Radiologic Pathology Archives.
 

Author(s): Jamie Marko, Darcy J Wolfman, Alex L Aubin, Isabell A Sesterhenn

Journal: Radiographics. ;37(4):1085-1098.

 

Testicular seminoma is the most common malignant tumor of the testis. It classically manifests as a painless mass. Radiologic evaluation with high-frequency ultrasonography (US) is critical for diagnosis. Seminomas are usually homogeneously hypoechoic masses at US. In challenging ...

Last Updated: 31 Dec 1969

Go To URL
Adjuvant treatment for Stage I seminoma: Why radiotherapy is better than carboplatin.
 

Author(s): Prahlad H Yathiraj, Krishna Sharan, Donald J Fernandes, M S Vidyasagar

Journal: J Cancer Res Ther. ;12(4):1216-1219.

 

Adjuvant treatment options for Stage I seminoma include active surveillance, chemotherapy, and radiotherapy. Active surveillance may not be ideal for the average Indian patient. Of the two accepted adjuvant therapy options, namely single-dose carboplatin chemotherapy and radiotherapy ...

Last Updated: 31 Dec 1969

Go To URL
Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.
 

Author(s): Frank Kunath, Annabel Spek, Katrin Jensen, Friedemann Zengerling, Stefanie Schmidt

Journal:

 

Testicular cancer is primarily treated with the surgical removal of the affected testis. About 50% of testicular cancer patients present with a stage I seminoma. If no chemo- or radiotherapy as adjuvant treatment is initiated after orchiectomy, 15-20% of these patients will develop ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
 

Status: Recruiting

Condition Summary: Seminoma

 

Last Updated: 8 Jun 2016

Go to URL
Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma
 

Status: Recruiting

Condition Summary: Lymphadenopathy; Stage I Testicular Seminoma; Stage II Testicular Seminoma

 

Last Updated: 18 Jul 2018

Go to URL
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
 

Status: Recruiting

Condition Summary: Testicular Neoplasms; Seminoma

 

Last Updated: 23 Oct 2017

Go to URL